Ogut, Ozgur, and Frank V. Brozovich. Determinants of the contractile properties in the embryonic chicken gizzard and aorta. Am J Physiol Cell Physiol 279: C1722-C1732, 2000.-Smooth muscle is generally grouped into two classes of differing contractile properties. Tonic smooth muscles show slow rates of force activation and relaxation and slow speeds of shortening (V max ) but force maintenance, whereas phasic smooth muscles show poor force maintenance but have fast V max and rapid rates of force activation and relaxation. We characterized the development of gizzard and aortic smooth muscle in embryonic chicks to identify the cellular determinants that define phasic (gizzard) and tonic (aortic) contractile properties. Early during development, tonic contractile properties are the default for both tissues. The gizzard develops phasic contractile properties between embryonic days (ED) 12 and 20, characterized primarily by rapid rates of force activation and relaxation compared with the aorta. The rapid rate of force activation correlates with expression of the acidic isoform of the 17-kDa essential myosin light chain (MLC 17a ). Previous data from in vitro motility assays (Rover AS, Frezon Y, and Trybus KM. J Muscle Res Cell Motil 18: 103-110, 1997) have postulated that myosin heavy chain (MHC) isoform expression is a determinant for V max in intact tissues. In the current study, differences in V max did not correlate with previously published differences in MHC or MLC 17a isoforms. Rather, V max was increased with thiophosphorylation of the 20-kDa regulatory myosin light chain (MLC 20 ) in the gizzard, suggesting that a significant internal load exists. Furthermore, V max in the gizzard increased during postnatal development without changes in MHC or MLC 17 isoforms. Although the rate of MLC 20 phosphorylation was similar at ED 20, the rate of MLC 20 dephosphorylation was significantly higher in the gizzard versus the aorta, correlating with expression of the M130 isoform of the myosin binding subunit in the myosin light chain phosphatase (MLCP) holoenzyme. These results indicate that unique MLCP and MLC 17 isoform expression marks the phasic contractile phenotype.
SMOOTH MUSCLE CONTRACTION controls the tone of many involuntary muscles, such as those lining arteries and the walls of the stomach. On the basis of their contraction profiles in response to K ϩ depolarization (43) , smooth muscles are divided into two general contractile phenotypes: tonic and phasic. Tonic smooth muscles demonstrate slow rates of force activation and relaxation, lower maximum speeds of shortening (V max ) as well as force maintenance, whereas phasic smooth muscles display rapid rates of force activation and relaxation and have a high V max but poor force maintenance (reviewed in Ref. 15 ). In both smooth muscle types, phosphorylation of the 20-kDa regulatory myosin light chains (MLC 20 ) by Ca 2ϩ -calmodulin-activated myosin light chain kinase (MLCK) promotes actomyosin cycling to produce force. Although previous studies have suggested that isoform expression of myosin and actin filament-associated proteins are molecular determinants of the contractile properties of smooth muscle (46) , the molecular determinants of the unique contractile properties of phasic versus tonic smooth muscle phenotypes remain unclear.
Proteins controlling the activation of the myosin ATPase activity, namely MLCK and myosin light chain phosphatase (MLCP), have been suggested as candidates that define contractile properties in phasic and tonic smooth muscles (12, 23) . These proteins control MLC 20 phosphorylation and therefore the level of activation. However, the unique rates of force activation in phasic and tonic smooth muscles are not simply explained by differences in Ca 2ϩ transients or rates of MLC 20 phosphorylation because phasic tissues maintain higher rates of force activation when skinned or when the MLC 20 is thiophosphorylated to dissociate force activation from MLCK and MLCP kinetics (22) . Nonetheless, maximum shortening velocity (V max ) in smooth muscle is related to the level of activation as defined by MLC 20 phosphorylation (1, 10) . Furthermore, it has been proposed that MLCP may play a role in the regulation of relaxation because protein kinase C activation and subsequent MLCP inhibition decreases the rate of MLC 20 dephosphorylation and force relaxation (25, 34) , parameters thought to reflect a decrease in MLCP catalytic activity. Moreover, the MLCP holoenzyme may exist as isoforms, which differ in the expression of two unique myosin binding subunits (M130/M133; Ref. 41) . Therefore, in addition to contractile protein isoform diversity, the control of actomyosin kinetics in smooth muscle may also rely on factors modulating MLC 20 phosphorylation.
The smooth muscle myosin heavy chain (MHC) is a single gene with two pairs of alternatively spliced exons. Two isoforms, named SM1 and SM2, differ by expression of a 43-or 9-amino acid COOH-terminus, respectively (5) . Their contribution to contractility remains controversial (2, 27, 36) . In addition, alternative splicing of an exon near the NH 2 -terminal 25-to 50-kDa junction of the myosin head accounts for a 7-amino acid insert in visceral SM1 and SM2 MHCs (28) . MHC isoform diversity at the NH 2 -terminus has been hypothesized as a determinant of the tonic and phasic contractile properties in smooth muscle (28, 30, 46) . Additionally, the 17-kDa essential myosin light chains (MLC 17 ) associated with the neck region of MHCs also show isoform diversity. Two splice variants of MLC 17 have been found in smooth muscle, and they differ by inclusion (MLC 17b ) or exclusion (MLC 17a ) of a 39-bp exon (38) . Studies have shown a correlation between increased MLC 17b expression and decreased actin activated Mg 2ϩ -ATPase activity of myosin (18) as well as decreased V max in intact tissues (31) .
We assumed that the major factors controlling the contractile properties of developing gizzard and aortic smooth muscle would be the myosin isoforms (MHC and MLC 17 ) or proteins controlling myosin activation through MLC 20 phosphorylation (MLCK and MLCP). Because MHC and MLC 17 isoforms switch during development of the embryonic chicken aorta and gizzard (7), we hypothesized that changes in protein isoform expression throughout development would be reflected by changes in the contractile phenotype. Therefore, we investigated MHC, MLC 20 , MLC 17 , MLCK, MLCP, and thin filament-associated proteins to determine the markers for phasic and tonic contractile properties. In the aorta and gizzard, the tonic phenotype was the default during early embryonic development. Approximately 1 wk before hatching, the phasic phenotype developed in the gizzard. We demonstrate that the MLC 17 and MLCP isoforms are molecular markers for the phasic contractile phenotype. Expression of MLC 17a defined the rapid rate of force activation, whereas expression of a gizzard-specific MLCP isoform was a determinant for the rapid rate of relaxation, both hallmarks of phasic smooth muscles.
MATERIALS AND METHODS
Identification of regulatory protein isoforms in the embryonic chicken. Fertilized chicken eggs were incubated at 37°C in humidified air and collected at embryonic days (ED) 10, 12, 14, 16, 18 , and 20. The gizzard and thoracic aortas from five or more embryos were dissected in Ca 2ϩ -free physiological saline solution (in mM: 140 NaCl, 4.7 KCl, 0.3 Na 2 HPO 4 , 2 MOPS, 0.5 EGTA, 0.2 EDTA, 1.2 MgCl 2 , 5.6 glucose, final pH adjusted to 7.4 with 1 N KOH). The tissues were immediately homogenized in SDS-PAGE buffer, heated to 80°C for 5 min, and clarified by centrifugation at 14,000 g in a microcentrifuge. The samples were resolved by either 12% SDS-PAGE with an acrylamide-to-bisacrylamide ratio of 29:1 (calponin, MLC 20 ) or 14% SDS-PAGE with an acrylamide-to-bisacrylamide ratio of 180:1 (MLCK, myosin binding subunit of MLCP). To ensure comparable sample loading, the samples were normalized according to the G-actin band in SDS-PAGE. Once sample loadings were comparable, the SDS-PAGE-resolved proteins were transferred to 0.22-m nitrocellulose membrane in a transfer buffer (100 mM glycine, 10 mM Tris, pH 8.6, 20% methanol) and blocked at room temperature for 3 h using Tris-buffered saline (TBS; 150 mM NaCl, 50 mM Tris ⅐ HCl, pH 7.4) containing 1% BSA. Blocked nitrocellulose membranes were incubated overnight at 4°C in TBS-0.1% BSA with monoclonal antibodies (MAbs) against calponin (CP1; 26), MLC 20 (My-21; Sigma Immunochemicals), MLCK (LKH3 and LKH18; Ref. 6), or MLCP myosin binding subunit (Covance). For MLCK identification, a purified smooth muscle MLCK protein sample was used as a control. The membranes were washed three times for 10 min in TBS containing either 0.05% Tween 20 or 0.5% Triton X-100-0.05% SDS and then rinsed with TBS. The membranes were subsequently incubated with TBS-0.1% BSA containing alkaline phosphatase-conjugated goat anti-mouse IgG or IgM second antibody for 50 min at room temperature. After membranes were washed after second antibody incubation, the color reaction was developed in alkaline phosphatase substrate buffer (in mM: 110 NaCl, 5 MgCl 2 , 100 Tris, final pH 9.5) containing 0.04% (wt/vol) nitro blue tetrazolium and 0.02% (wt/vol) 5-bromo-4-chloro-3-indolylphosphate.
Tissue strips from ED 12, 16, and 20 aorta and gizzard were also freshly dissected and fixed in buffered Formalin solution for paraffin embedding. The tissues were sectioned at 7 m and stained with hematoxylin and eosin according to standard protocols.
Force of contraction of developing chicken gizzard and aorta. Embryonic chicken gizzard and aorta strips were excised from embryos at various stages of development, skinned, and allowed to contract in high Ca 2ϩ (0.1 mM free Ca 2ϩ ) and relax in low Ca 2ϩ (1 nM free Ca 2ϩ ) solutions. The solutions were mixed according to a computer program that calculated the amount of stock solutions required for a given set of free ion concentrations (3). The binding constants for the ionic species present were corrected for temperature and ionic strength. The strips were clipped between two aluminum foil T clips (11) To measure the rate of force activation or the rate of relaxation, tissue strips were skinned and allowed to contract in the pCa4 activating solution until force reached a steady plateau and then allowed to relax by transferring the tissues to pCa9 relaxing solution. The contraction profiles were stored on a digital oscilloscope (Nicolet 310). To determine a rate, the force activation and relaxation profiles were fit to a single exponential. Results are reported as the average Ϯ SE. Differences were deemed significant if P Ͻ 0.05 by Student's t-test.
Experiments were also done wherein MLC 20 was thiophosphorylated to assure maximal activation of myosin heads during contraction (20) . To thiophosphorylate MLC 20 , skinned tissues were incubated for 5 min in an activating solution wherein 5.56 mM (5 mM free) ATP-␥-S (Calbiochem) was substituted for ATP and creatine phosphate. The tissues were then transferred into pCa9 relaxing solution containing ATP and force developed. The rates of force activation for thiophosphorylated tissues were determined as described above.
V max in developing chicken gizzard and aorta. The unloaded speed of shortening of the skinned tissues was determined from the force versus velocity relationship (19) . A computer program based on Smith and Barsotti (42) was written in LabView (National Instruments, Dallas, TX) to control length for constant loads. Force and length signals were sampled and controlled using an analog-to-digital-digital-to-analog board (National Instruments PCI-MIO-16XE-10, 100 ϫ 10 3 samples/s, 16 bit). After activation of the gizzard and aorta strips, the load on the tissues was decreased to any set percentage of the isometric force. The tissues were maintained at a fraction of the initial isometric load (1-90%) by a program monitoring tension (200-300 samples/s) and rapidly adjusting (shortening) length to provide constant load. A force clamp from an initial tone to any desired new load was achieved within 10 (300 samples/s) to 30 ms (200 samples/s). The shortening profiles of the tissues were saved, and the speed of shortening at various loads was calculated from the tangent to the length versus time trace at 150 ms after the step change in load. The unloaded speed of shortening was calculated by fitting the force versus velocity relationship to the Hill equation (19) or taken as the speed of shortening at 1% of initial isometric load (42) . The speeds of shortening were normalized to muscle lengths per second (ML/s). For each tissue, at least three separate measurements were taken at each load tested; n represents the number of tissues tested. However, the V max for smooth muscles before ED 12 could not be reliably determined because of the low forces of Ca 2ϩ -activated contractions. Results are presented as the average Ϯ SE.
Analysis of MLC 20 phosphorylation in developing chicken gizzard and aorta. To determine the extent of phosphorylation of MLC 20 , a glycerol-urea-PAGE procedure (17) was adapted to resolve the phosphorylated and unphosphorylated forms of MLC 20 . Strips of chicken gizzard or aorta were skinned as before, washed, and resuspended in the relaxing buffer. To measure the rate of phosphorylation of MLC 20 , tissue strips were incubated for 0, 30, 60, 120, and 300 s in pCa4 activating solution. Activation of the strips was terminated by adding excess 15% (vol/vol) trichloroacetic acid in acetone. The tissues were frozen in liquid nitrogen for 30 min. After denaturation, the tissue strips were washed twice with acetone, dried using a Speed-Vac evaporator and homogenized in PAGE sample buffer containing 6 M urea, 20 mM glycine, 22 mM Tris ⅐ HCl, pH 8.6, and 1 mM EDTA. Glycerol (5% vol/vol) and bromophenol blue (0.1% wt/vol) were added to the samples before loading. The samples were resolved by a 19:1 (acrylamide-bisacrylamide) 10% polyacrylamide gel containing 40% (vol/vol) glycerol and 4 M urea and polymerized in a gel buffer containing 20 mM glycine and 22 mM Tris ⅐ HCl, pH 8.6. The gel was prerun in the electrophoresis buffer (20 mM glycine, 22 mM Tris ⅐ HCl, pH 8.6, 1 mM thioglycolic acid) for 1 h at 200 V before loading of the samples. The samples were resolved overnight at 200 V or roughly 2 h after the bromophenol blue dye front had exited the gel. Resolved proteins were transferred to nitrocellulose membrane, and the phosphorylated and unphosphorylated MLC 20 were identified by immunoblotting as described earlier. The percentage of MLC 20 phosphorylated was calculated by determining the ratio of the phosphorylated MLC 20 band versus the total MLC 20 (phosphorylated ϩ unphosphorylated forms) identified by the mAb.
The rate of dephosphorylation of MLC 20 was measured in a fashion similar to phosphorylation. After the tissue strips were skinned, all were activated for 300 s in the activation buffer. After activation, the strips were allowed to relax in a Ca 2ϩ -free rigor solution without ATP or creatine phosphate (173 mM potassium methane sulfonate, pH 7, 5 mM EGTA, 12 M CaCl 2 , 1.16 mM MgCl 2 , 25 mM BES, final pH to 7 with 1 N KOH) for 0, 30, 60, 120, and 300 s. The dephosphorylation was terminated by denaturing the tissue strips in 15% trichloroacetic acid in acetone. The tissues were prepared for glycerol-urea-PAGE as before. For phosphorylation and dephosphorylation experiments, results are expressed as the average Ϯ SE of three paired experiments. The experimental data were well fit to a single exponential.
Tissue strips were also activated with ATP-␥-S as described before, and the extent of thiophosphorylation was determined by glycerol-urea-PAGE. Thiophosphorylation of MLC 20 was near 100% in samples of aorta (86.9 Ϯ 6.6%, n ϭ 3) and gizzard (89.6 Ϯ 9.3%, n ϭ 3) incubated for 300 s in thiophosphorylation solution. To ensure that tissues were thiophosphorylated as intended, glycerol-urea-PAGE was also performed on samples that were incubated in the dephosphorylation buffer for 300 s after thiophosphorylation. Because thiophosphorylated MLC 20 is not a substrate for MLCP, the high percentage of thiophosphorylated MLC 20 should remain. This was confirmed by the persistence of the phosphorylated form of MLC 20 in glycerolurea-PAGE analysis of both the aorta (90.2 Ϯ 5.0%; n ϭ 3) and the gizzard (89.7 Ϯ 9.5%, n ϭ 3) after 300 s incubation in the Ca 2ϩ -free rigor solution.
RESULTS
Rapid rate of force activation in the developing gizzard. Representative contraction profiles for embryonic aorta and gizzard at various stages demonstrate the development of the contractile phenotypes of these tissues (Fig. 1) . Both smooth muscle tissues show a slow rate of force activation early during embryonic development . The faster contractile properties of the gizzard strips become apparent by ED 16, with clearly increased rates of force activation and relaxation compared with the aorta (Table 1 and see  Table 6 ). The rates of activation between ED 12 gizzard and aorta were not different (P Ͼ 0.05). Although the rates of force activation were not significantly different between ED 16 and 20 gizzard, they were always significantly faster than either ED 16 or 20 aorta (P Ͻ 0.05). The rates of force activation increased with development in the gizzard and were significantly faster at ED 20 versus ED 12 (P Ͻ 0.05). Thiophosphorylation of MLC 20 significantly increased the rates of force activation in both ED 20 aorta (0.018 Ϯ 0.003 s
Ϫ1
) and gizzard (0.060 Ϯ 0.009 s Ϫ1 ) versus Ca 2ϩ activation (P Ͻ 0.05). However, the rate of force activation for ED 20 gizzard remained threefold faster than for ED 20 aorta with or without thiophosphorylation.
Orientation of cells in the developing aorta and gizzard. To determine whether changes in the orientation of the cells were occurring with development, ED 12, 16, and 20 aorta and gizzard sections were stained with hematoxylin and eosin (Fig. 2) . With development in both tissues, an increase in cell density was apparent. In the aorta, there was no change in the orientation of the cells with development. In the gizzard, however, the orientation of cells changed by ϳ20°between ED 12 and 16, with cells changing from parallel to the axis of the strip at ED 12 to 20°off the axis at ED 16. No subsequent change in cell orientation was observed from ED 16 to 20 gizzard.
Protein isoform expression in the developing aorta and gizzard. The expression of multiple regulatory protein isoforms is a common theme in developing muscle. Representative smooth muscle-specific markers were chosen, and their isoform expression throughout development of the embryonic chicken gizzard and aorta was monitored (Fig. 3) . Calponin, an actin filament-associated marker of smooth muscle, was present throughout development of the gizzard and aorta as a single isoform. Using MAb MY-21 (Sigma), we identified a single isoform of MLC 20 expressed throughout development of the aorta and gizzard. Comparison of the expression of the M130/M133 isoforms of the myosin binding subunit of MLCP (41) indicated that only M133 was expressed throughout development of the aorta. On the other hand, a developmental isoform switch of M130 for M133 was observed in the developing gizzard, with M130 expression beginning at ED 20. This is consistent with upregulation of M130 expression to become the dominant myosin binding subunit isoform expressed in adult chicken gizzard (41) . The smooth muscle MLCK isoform was the abundant MLCK isoform expressed in both the gizzard and aorta during embryonic development. Because the Western blots only monitored isoform expression, we could not make any conclusions with respect to changes in protein content with development.
Force of contraction of the developing gizzard and aorta. We measured the force per cross-sectional area in developing aorta and gizzard to determine whether a correlation could be made with myosin isoform expression. Although the force per cross-sectional area increased with development for both embryonic aorta and gizzard (Table 2) , ED 20 gizzard was significantly higher (P Ͻ 0.05) than ED 20 aorta, with or without thiophosphorylation of the myosin regulatory light (Table 5 ). . The rates of force activation were defined from single exponential fits to the data. ED, embryonic day.
chain. The increases in force per cross section may be achieved by differences in actin/myosin content or tissue content of smooth muscle.
V max in embryonic chicken gizzard and aorta. To monitor changes in V max with development of the smooth muscle contractile phenotypes, the V max for embryonic aorta and gizzard strips was determined at three stages of development. The V max for the developing aorta was higher than for the developing gizzard at all stages (Table 3) . This was surprising given that adult phasic tissues have faster speeds of shortening than tonic tissues (15 -activated skinned gizzard strips from 1-wkold chicks indicated that V max increased after hatching (0.115 Ϯ 0.013 ML/s, n ϭ 3). Therefore, V max continues to increase significantly after birth, given that adult chicken gizzard strips have a V max of ϳ0.3 ML/s (1). Force-velocity curves of thiophosphorylated fibers showed that the shortening velocity as a percentage of V max (Fig. 4B) achieved by the gizzard was higher at most loads compared with the aorta. The extent of MLC 20 thiophosphorylation in the preparations was comparable (Table 4) .
Time course of MLC 20 phosphorylation and dephosphorylation. To assess whether phosphorylation-dephosphorylation of MLC 20 played a significant role in the rates of force activation and relaxation, we determined the time to reach half-maximal phosphorylation and dephosphorylation in skinned ED 16 and 20 aorta and gizzard. We chose ED 16 and 20 because phasic and tonic contractile phenotypes appeared to be well established at these days of development. The levels of MLC 20 phosphorylation in the gizzard and aorta after 0 or 300 s of activation were not significantly different (Fig. 5 ). Both ED 20 aorta and gizzard showed similar levels of maximum MLC 20 phosphorylation (aorta, 47.3 Ϯ 4.0%, n ϭ 7; gizzard, 44.2 Ϯ 3.3%, n ϭ 7), which were not different from ED 16 aorta (42.6 Ϯ 5.0%, n ϭ 8) or gizzard (42.7 Ϯ 4.6%, n ϭ 7), indicating that the maximum level of activation does not change between ED 16 and 20. Likewise, for dephosphorylation experiments, we found no difference between the level of MLC 20 phosphorylation in the gizzard and aorta after 0 or 300 s of dephosphorylation (Fig. 6) .
Our experiments characterizing the time course of MLC 20 phosphorylation in ED 20 aorta and gizzard showed no significant difference between the two tissues. However, MLC 20 phosphorylation was near maximal at 30 s, which was the first time point measured.
Therefore, calculation of the time for half-maximal phosphorylation of MLC 20 would very likely be an underestimate of the actual time course and may mask differences in the rates of MLC 20 phosphorylation. Nonetheless, maximum force in the skinned smooth muscles was achieved well after 30 s (Fig. 1) , indicating that maximum MLC 20 phosphorylation preceded maximum force. Therefore, the time course of MLC 20 phosphorylation would not be rate limiting for the rate of force activation in ED 20 aorta and gizzard. Values are means Ϯ SE in muscle lengths (ML/s). All unloaded speeds of shortening were determined from shortening speeds of tissues maintained at 1% of isometric load, except ED 20 aorta and ED 20 aorta treated with ATP-␥-S, where the unloaded speed of shortening of 3 and 4 of the tissues, respectively, were calculated by extrapolation of the Hill equation. (Table 5) .
Rate of force relaxation in embryonic chicken smooth muscles. We measured the rates of force relaxation for skinned embryonic gizzard and aorta strips at ED 12, 16, and 20 (Table 6 ) to determine whether relaxation could be correlated with differences in the rate of dephosphorylation of MLC 20 . For ED 12, 16 , and 20 aorta, rates of relaxation were 0.001 Ϯ 0.001 (n ϭ 3), 0.004 Ϯ 0.001 (n ϭ 5), and 0.005 Ϯ 0.002 s Ϫ1 (n ϭ 7), respectively. These were not different from the rate of relaxation of ED 12 gizzard (0.003 Ϯ 0.002 s Ϫ1 , n ϭ 3). However, the rates of relaxation for ED 16 gizzard (0.019 Ϯ 0.002 s Ϫ1 , n ϭ 8) and ED 20 gizzard (0.030 Ϯ 0.004 s
, n ϭ 8) were significantly faster compared with the aorta (P Ͻ 0.05). Furthermore, the rate of relaxation in ED 20 gizzard was significantly faster (P Ͻ 0.05) than in ED 16 gizzard.
DISCUSSION

Regulatory protein isoform heterogeneity during development.
Through development, regulatory proteins may be expressed as multiple isoforms. During chicken development, MHC and MLC 17 expression both show default tonic phenotypes at early embryonic stages, with expression of MLC 17b and noninsert containing MHC (7) . However, in the gizzard, polymerase chain reaction and Western blot analyses have shown that expression of the 7-amino acid insert containing MHCs dominates expression in SM1 and SM2 MHC isoforms from ED 10 (Ͼ70%) to adult (ϳ100%; 7, 28), whereas the aorta did not express the 7-amino acid insert in SM1 and SM2 myosins. Furthermore, MLC 17a expression is upregulated with development to hatching in the gizzard (Ͼ50% at ED 12, Ͼ70% at ED 16, and ϳ100% for adult; 7, 28), whereas MLC 17b is predominant throughout aorta development (Ͼ60% from ED 12 to adult; 7, 28). Therefore, in the gizzard, MHC and MLC 17 isoform maturation correlates with development of the phasic phenotype.
We detected expression of only the smooth musclespecific MLCK isoform in both the developing gizzard and aorta (Fig. 3) , suggesting that isoform switching of (Fig.  3) , consistent with M130 being the dominant isoform expressed in the adult (41) . On the other hand, the M133 subunit was constitutively expressed in the developing aorta. Therefore, expression of a gizzard-specific MLCP holoenzyme may contribute to the differences in phasic versus tonic contractile properties.
Kinetics of MLC 20 phosphorylation in embryonic gizzard and aorta. Although MLC 20 phosphorylation controls smooth muscle force production, the increased rate of force activation in the gizzard is not well explained by MLCK activity. Phosphorylation of MLC 20 in both aorta and gizzard preceded maximal force activation (see Figs. 1 and 5 ). In addition, both tissues expressed identical MLCK isoforms (Fig. 3 ) and reached the same maximum level of MLC 20 phosphorylation (Fig. 5) . However, between ED 20 gizzard and aorta, we detected a significant difference in the time course of MLC 20 dephosphorylation (Fig. 6) . If MLCP activity is constitutive in the presence and absence of Ca 2ϩ , this implies that steady-state MLCK activity was higher in ED 20 gizzard than in the aorta. This difference was not resolved on the time scale of our in vitro phosphorylation experiments. However, the difference between MLCK activity for the aorta and gizzard can be determined assuming that the steady-state level of MLC 20 phosphorylation is defined by MLCK and MLCP activities as described by MLCK/(MLCK ϩ MLCP). Because steady-state MLC 20 phosphorylation levels were not significantly different between ED 20 aorta and gizzard (ϳ45%) and assuming that the rates of dephosphorylation are accurate, the MLCK activity in the aorta would calculate to 41% of that in the gizzard. This implies that the rates of phosphorylation were underestimated. Although thiophosphorylation of MLC 20 in ED 20 aorta and gizzard increased the rates of force activation compared with phosphorylation of MLC 20 , an approximately threefold difference remained (Table 1) in the rates of force activation in these tissues. Therefore, MLC 20 phosphorylation was not a limiting factor in the slow rate of force activation in the aorta, indicating that with phasic muscle the rapid rate of force activation is not explained by increased MLCK activity alone. Thus although the steady-state MLCK activity may be higher in the gizzard, its contribution to the differences in the rates of Ca 2ϩ -activated force appears to be small. Furthermore, differences in the rates of force activation between aorta and gizzard are unlikely to be due to diffusional effects. Activation of thiophosphorylated gizzard fibers (wherein ATP diffusion is limiting) showed that diffusion can sustain rates Ͻ0.060 s Ϫ1 . Therefore, the differences in the rates of force activation in Ca 2ϩ -activated gizzard and aorta fibers (wherein rates were Ͻ0.02 s
Ϫ1
) would not be due to diffusion. In fact, thiophosphorylated phasic and tonic tissues activated by photolysis of caged ATP still show significant differences in the rates of force activation (21) . With flash photolysis, diffusion is not a factor and differences in the rates of force activation point to unique kinetics of the actomyosin interaction in these tissues. In addition, the differences in the rates of force activation for Ca 2ϩ -activated smooth muscle strips was not due to differences in calmodulin content (or loss) after skinning, because thiophosphorylation achieved near complete levels of MLC 20 phosphorylation in both ED 20 aorta and gizzard (Table 4) while preserving the differences in the rates of force activation (Table 1) . We also considered the possibility that changes in maximum force could be due to variations in the orientation of sarcomere equivalents. However, because force is related to the cosine of the angle between the axis of tissue preparation and the orientation of the cells, large changes in angle (Ͼ60°) would be required to affect maximum force by twofold. The data in Fig. 2 demonstrate that changes in cell orientation were not an issue with the developing aorta. In the gizzard, the ϳ20°change in orientation between ED 12 and 16 would result in the underestimation of the measured force at ED 16 and 20 by ϳ6%. This suggests that the increase in force with development is due to more smooth muscle cells per cross section; this is supported by data that the force per stiffness is not significantly different with development (data not shown). However, the orientation of cells is a factor only for the force measured, not the rate of force activation. The data indicate that the primary determinant for the rapid rate of force activation in the gizzard is at the level of the actin and myosin filaments. Because the MLC 20 phosphorylation measurements (Fig. 5) were done on skinned preparations activated directly with Ca 2ϩ , we excluded possible modulation of MLCK activity in the aorta and gizzard through second messenger pathways (44), but not through Ca 2ϩ -activated kinases. However, thiophosphorylated fibers maintained differences in the rates of force activation, downplaying the importance of Ca 2ϩ -activated kinases (other than MLCK), unless a kinase was specifically coupled to the contractile apparatus in only gizzard or only aortic smooth muscle. Therefore, differences in the rates of force activation between gizzard and aortic smooth muscle remain in the absence of tissue-specific agonist-dependent pathways that differentially modulate MLCK/ MLCP activity through phosphorylation (9). . The rates of relaxation were defined from single exponential fits to the data.
Rates of MLCP dephosphorylation in developing gizzard and aorta. There was a significant difference in the rates of MLC 20 dephosphorylation between ED 20 gizzard and ED 16 gizzard or ED 16 and 20 aorta (Table 5 ; Fig. 6 ). The increased rate of MLC 20 dephosphorylation in ED 20 gizzard correlated with expression of a unique isoform of the myosin binding subunit of MLCP (M130; 16, 41) that was not expressed in the aorta (Fig. 3) . There was no difference in the rates of dephosphorylation in ED 16 aorta and gizzard versus ED 20 aorta (Table 4) , wherein all smooth muscle tissues expressed M133. Therefore, our results suggest that the MLCP holoenzyme containing the M130 myosin binding subunit correlates with the increased rate of MLC 20 dephosphorylation in ED 20 gizzard, either through increased activity of this MLCP holoenzyme or an increase in the MLCP-to-myosin ratio. Coupled with data characterizing the rates of force relaxation, two conclusions may be drawn. First, we demonstrated that the rate of relaxation in the gizzard is faster than in the aorta at both ED 16 and 20. At ED 16, both tissues express the MLCP holoenzyme with the M133 subunit and show similar time courses for MLC 20 dephosphorylation. Therefore, the differences in the rates of force relaxation between ED 16 aorta and gizzard (Table 6) are best attributed to changes in the kinetics of the myosin isoforms in the cross-bridge cycle, likely due to inclusion (gizzard) or exclusion (aorta) of the 7-amino acid insert in the MHC or different MLC 17 isoform expression in the two tissues. With laser trap experiments, it has been demonstrated that heavy meromyosin composed of the noninsert (aortic) form of MHC has an attachment time on actin roughly twice as long as the insert (gizzard) form (30) . This would agree with our results that relaxation in ED 16 gizzard is faster than in ED 16 aorta, although the tissues show similar rates of MLC 20 dephosphorylation. Nonetheless, the increase in the rate of relaxation of ED 20 versus 16 gizzard indicates that expression of MLCP holoenzymes containing the M130 myosin binding subunit correlates with increases in the rate of MLC 20 dephosphorylation and thus the rate of force relaxation, whether by increased MLCP isoform activity or increased MLCP-to-myosin ratio.
Unloaded speed of shortening in developing chicken gizzard and aorta. Previous reports have demonstrated that increased MLC 17a content may account for faster speeds of shortening in smooth muscle tissues (31) . Increasing the proportion of MLC 17a expression by exchange of MLC 17 isoforms in trifluoperazinetreated smooth muscle was also shown to increase the shortening velocity (35) , although contraction in these tissues was independent of Ca 2ϩ or MLC 20 phosphorylation. On the other hand, in in vitro motility assays, exchange of MLC 17 isoforms had no effect on the speed of actin filament movement by myosins (28, 40) . Although the embryonic gizzard expressed a higher proportion of MLC 17a than the aorta (7), in our study, the gizzard had slower speeds of shortening under all conditions tested (Table 3) . Therefore, MLC 17a content was not a factor in defining a faster V max in these tissues. It remains a possibility that changes in content or isoform of calponin and caldesmon (37) may contribute to the mechanical parameters measured in these experiments.
Interestingly, after thiophosphorylation of MLC 20 , there was a significant increase in the speed of shortening in the gizzard, without a significant change in the aorta. This implies that there is a higher internal load on ED 20 gizzard cells, which is overcome by maximal (ϳ90%) phosphorylation of MLC 20 or by increasing the level of activation of the preparation. This result is similar to cardiac muscle wherein shortening velocity is dependent on the level of Ca 2ϩ activation (33) . In fact, the V max of Ca 2ϩ -activated gizzard strips increases 1 wk after hatching, approaching the V max of ϳ0.3 ML/s measured from adult chicken gizzard strips (1) . The postnatal increases in V max occur independent of changes in the level of MLC 20 phosphorylation from ED 20 (this study) to adult (1) or differences in MHC/ MLC 17 isoform expression, because myosin expression has already matured to the adult patterns by ED 20. Experiments characterizing isolated myosins in in vitro motility assays (28, 40) have indicated that intestinal myosins propel actin filaments faster, along with having a higher actin-activated Mg 2ϩ -ATPase activity, although care must be taken when interpreting data from in vitro motility assays (13) . With the optical trap, the MHC determined the kinetics of cross-bridge attachment (30) . Nonetheless, our data indicate that because of a significant internal load, the level of activation is a major factor in determining V max (1, 10) . The presence of an internal load in single smooth muscle cells has been shown previously to affect the extent of shortening (47) . In the case of ED 20 gizzard, the internal load was overcome by increasing the level of MLC 20 phosphorylation from 45 to 90% in thiophosphorylated fibers, presumably increasing the number of actively cycling, force-generating myosin heads. In fact, the increase in V max of the gizzard with development from hatching to birth and after birth takes place in the absence of changes in myosin isoforms or MLC 20 phosphorylation. One possible explanation for the increase is a decrease in the internal load on gizzard myosins with maturation, either defined by changes in the intracellular or extracellular matrix properties. This is also supported by the significant increase of V max with development of the aorta wherein there is a modest change in MLC 17 isoform expression but no changes in MHC isoform expression or MLC 20 phosphorylation. Thus changes in internal load and thus the level of activation or MLC 20 phosphorylation appears to be the major determinant of V max in this model.
Role of MLC 17 isoforms in determining tonic and phasic contractile properties. It is well known that the 20-kDa regulatory myosin light chains play a defining role in controlling actomyosin interaction in smooth muscle. However, the function of the 17-kDa essential myosin light chain has not been as well characterized. The essential myosin light chains line the neck region of the MHC dimers, possibly acting as a scaffold for this extended helix (39) . In this respect, the interaction of different MLC 17 isoforms with the neck region of MHC dimers may result in changes in the stiffness of this lever arm. The rapid rate of force activation in the gizzard due to MLC 17a expression may be explained if this isoform provided added stiffness to the myosin lever arm.
If MLC 17 is a determinant in regulating the actomyosin cross bridge's ability to bear a load, then we would expect that speed of shortening would be higher with MLC 17a than MLC 17b at or near physiological loads, as shown in Fig. 4 . In fact, the gizzard, which expresses predominantly MLC 17a , is able to develop a higher relative percentage of its V max at all loads compared with the aorta, which expresses predominantly MLC 17b . This is coupled by higher absolute isotonic shortening velocities at loads Ն40% of isometric level, supporting the conclusion that MLC 17 is a major determinant of the speed of contraction under physiological loads. In addition, MHC isoform contribution to the rate of force activation is not significant. This is supported by previous experiments demonstrating that endothelin-1 treatment of gizzard smooth muscle cells increased MLC 17b isoform expression, did not change MHC isoform expression, but decreased the rate of force activation (7) . Furthermore, transfection of single aortic smooth muscle cells with eukaryotic plasmids expressing MLC 17a increases the rate of force activation, whereas transfection of gizzard smooth muscle cells with MLC 17b decreases the rates of force activation, both in the absence of MHC isoform changes (24) .
In summary, we show that MLC 17 and MLCP are molecular markers for the phasic contractile phenotype of smooth muscle. The MLC 17 isoforms regulate the rate of force activation and expression of myosin binding subunit isoforms of the MLCP holoenzyme modulate the rate of force relaxation, two hallmarks for tonic and phasic contractile properties.
